Johnson Matthey (LON:JMAT) Insider Acquires £263.16 in Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Alastair Judge purchased 12 shares of the company’s stock in a transaction on Wednesday, August 12th. The stock was acquired at an average cost of GBX 2,193 per share, for a total transaction of £263.16.

Alastair Judge also recently made the following trade(s):

  • On Friday, July 10th, Alastair Judge bought 12 shares of Johnson Matthey stock. The shares were purchased at an average cost of GBX 1,909 per share, for a total transaction of £229.08.
  • On Wednesday, June 10th, Alastair Judge acquired 14 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,990 per share, for a total transaction of £278.60.

Johnson Matthey Trading Up 0.3%

JMAT opened at GBX 2,196 on Friday. Johnson Matthey PLC has a fifty-two week low of GBX 1,731.83 and a fifty-two week high of GBX 2,434. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. The company’s 50-day moving average is GBX 2,018 and its 200 day moving average is GBX 2,063.63. The firm has a market capitalization of £3.69 billion, a PE ratio of -38.39, a P/E/G ratio of 49,242.50 and a beta of 0.94.

Johnson Matthey (LON:JMATGet Free Report) last issued its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. The firm had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%. As a group, research analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

JMAT has been the topic of several research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 2,400 price target on shares of Johnson Matthey in a research report on Monday, July 6th. Berenberg Bank boosted their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a report on Monday, June 1st. UBS Group restated a “neutral” rating and issued a GBX 2,200 target price on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Jefferies Financial Group restated a “buy” rating and issued a GBX 2,330 target price on shares of Johnson Matthey in a research note on Tuesday, August 4th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of GBX 2,283.33.

Check Out Our Latest Report on Johnson Matthey

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

See Also

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.